Camerson E. Moore

FDA investigator

Appears on 48 documents from 2014 to 2026, mostly at sites in Texas. Most often cites control of microbiological contamination (21 CFR 211.113).

48
Documents on file
6.2
Observations per 483
2014
First seen
2026
Most recent

What they cite most

From 283 observations

Activity by year

2014: 2, 2015: 3, 2016: 3, 2017: 2, 2018: 3, 2019: 7, 2020: 3, 2021: 3, 2022: 6, 2023: 5, 2024: 4, 2025: 5, 2026: 2

Where

Texas 34 · Arkansas 3 · Alabama 2 · Canada 2 · Florida 1 · Italy 1

Is Camerson E. Moore coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

48 documents, newest first
FirmOpen
483 Greenwich RxSep 9, 2026 · Tomball, Texas
483 QuVa Pharma, IncMay 4, 2026 · Sugar Land, Texas
483 Empower Clinic Services, LLC dba EmpowerNov 14, 2025 · Houston, Texas
483 Empower Clinic Services, LLC dba EmpowerNov 3, 2025 · Houston, Texas
483 FARMAKEIO OUTSOURCING LLCSep 5, 2025 · Southlake, Texas
483 August Bioservices, LLCApr 18, 2025 · Nashville, Tennessee
483 Eag l e Ph arma Outsourcing LLCFeb 27, 2025 · Hoover, Alabama

About this profile

What does Camerson E. Moore inspect?

Camerson E. Moore appears on 48 documents on file covering 37 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and FDCA 501(a)(2)(A).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Camerson E. Moore is dated Sep 9, 2026.